Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Fungal infections are common in severe COVID-19 cases but their impact on disease severity is unclear.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

77% of recovered COVID-19 patients in Nepal experienced long-term symptoms like fatigue, hair loss, and breathing issues.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

The random forest model effectively helps diagnose COVID-19 using key factors like age and symptoms.

Insulin resistance linked to obesity may increase COVID-19 severity.

Hair loss doesn't affect COVID-19 severity.

AGA might indicate higher risk for severe COVID-19.

The combined Selencin treatment effectively reduces hair loss and improves hair health after COVID-19.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Stem cell therapies, especially adipose-derived ones, show promise for treating severe COVID-19 and related conditions.

A woman with ectopic Cushing's syndrome and COVID-19 passed away despite treatment.

Long COVID symptoms vary and are influenced by personal and health factors.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

COVID-19 causes more taste, smell, hair, memory, and concentration issues than other respiratory infections.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Vitamin D may help prevent or reduce hair loss after COVID-19.

Dr. SKS hair booster serum effectively treats hair loss caused by COVID-19.

Most skin issues were due to COVID-19, with some caused by vaccines or treatments, and were categorized into five types.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.